These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 12695673

  • 21. 17p13.1 microdeletion involving the TP53 gene in a boy presenting with mental retardation but no tumor.
    Schluth-Bolard C, Sanlaville D, Labalme A, Till M, Morin I, Touraine R, Edery P.
    Am J Med Genet A; 2010 May; 152A(5):1278-82. PubMed ID: 20425836
    [Abstract] [Full Text] [Related]

  • 22. Allelic deletion at chromosome 9p21(p16) and 17p13(p53) in microdissected sporadic dysplastic nevus.
    Park WS, Vortmeyer AO, Pack S, Duray PH, Böni R, Guerami AA, Emmert-Buck MR, Liotta LA, Zhuang Z.
    Hum Pathol; 1998 Feb; 29(2):127-30. PubMed ID: 9490270
    [Abstract] [Full Text] [Related]

  • 23. The level of deletion 17p and bi-allelic inactivation of TP53 has a significant impact on clinical outcome in multiple myeloma.
    Thanendrarajan S, Tian E, Qu P, Mathur P, Schinke C, van Rhee F, Zangari M, Rasche L, Weinhold N, Alapat D, Bellamy W, Ashby C, Mattox S, Epstein J, Yaccoby S, Barlogie B, Hoering A, Bauer M, Walker BA, Davies FE, Morgan GJ.
    Haematologica; 2017 Sep; 102(9):e364-e367. PubMed ID: 28550191
    [No Abstract] [Full Text] [Related]

  • 24. 17p13/TP53 deletion in B-CLL patients is associated with microRNA-34a downregulation.
    Dijkstra MK, van Lom K, Tielemans D, Elstrodt F, Langerak AW, van 't Veer MB, Jongen-Lavrencic M.
    Leukemia; 2009 Mar; 23(3):625-7. PubMed ID: 18818704
    [No Abstract] [Full Text] [Related]

  • 25. Targeted inactivation of p53 in human cells does not result in aneuploidy.
    Bunz F, Fauth C, Speicher MR, Dutriaux A, Sedivy JM, Kinzler KW, Vogelstein B, Lengauer C.
    Cancer Res; 2002 Feb 15; 62(4):1129-33. PubMed ID: 11861393
    [Abstract] [Full Text] [Related]

  • 26. Tumor suppressor genes and cancer of the human nervous system.
    Chung RY, Seizinger BR.
    Cancer Invest; 1991 Feb 15; 9(4):429-37. PubMed ID: 1884250
    [No Abstract] [Full Text] [Related]

  • 27. The percentage of cells with 17p deletion and the size of 17p deletion subclones show prognostic significance in chronic lymphocytic leukemia.
    Yuan YY, Zhu HY, Wu JZ, Xia Y, Liang JH, Wu W, Cao L, Wang L, Fan L, Li JY, Xu W.
    Genes Chromosomes Cancer; 2019 Jan 15; 58(1):43-51. PubMed ID: 30350431
    [Abstract] [Full Text] [Related]

  • 28. Chromosome 17p deletion in human medulloblastoma: a missing checkpoint in the Hedgehog pathway.
    De Smaele E, Di Marcotullio L, Ferretti E, Screpanti I, Alesse E, Gulino A.
    Cell Cycle; 2004 Oct 15; 3(10):1263-6. PubMed ID: 15467454
    [Abstract] [Full Text] [Related]

  • 29. Abnormalities in the p53 gene in tumors and cell lines of human squamous-cell carcinomas of the head and neck.
    Yin XY, Smith ML, Whiteside TL, Johnson JT, Herberman RB, Locker J.
    Int J Cancer; 1993 May 08; 54(2):322-7. PubMed ID: 8098018
    [Abstract] [Full Text] [Related]

  • 30. PARC: a potential target for cancer therapy.
    Nikolaev AY, Gu W.
    Cell Cycle; 2003 May 08; 2(3):169-71. PubMed ID: 12734414
    [No Abstract] [Full Text] [Related]

  • 31. Detection of aberrations of 17p and p53 gene in gastrointestinal cancers by dual (two-color) fluorescence in situ hybridization and GeneChip p53 assay.
    Takahashi Y, Nagata T, Asai S, Shintaku K, Eguchi T, Ishii Y, Fujii M, Ishikawa K.
    Cancer Genet Cytogenet; 2000 Aug 08; 121(1):38-43. PubMed ID: 10958939
    [Abstract] [Full Text] [Related]

  • 32. Correlation of myelodysplastic syndromes with i(17)(q10) and TP53 and SETBP1 mutations.
    Adema V, Larráyoz MJ, Calasanz MJ, Palomo L, Patiño-García A, Agirre X, Hernández-Rivas JM, Lumbreras E, Buño I, Martinez-Laperche C, Mallo M, García O, Álvarez S, Blazquez B, Cervera J, Luño E, Valiente A, Vallespí MT, Arenillas L, Collado R, Pérez-Oteyza J, Solé F.
    Br J Haematol; 2015 Oct 08; 171(1):137-41. PubMed ID: 25716545
    [No Abstract] [Full Text] [Related]

  • 33. Assignment of three loci: tumor suppressor protein-53 (TP53), retinoic acid receptor A (RARA), collagen 1A1 (COL1A1) to Syrian hamster chromosome 9. Evidence that this chromosome is homologous with human chromosome 17, mouse chromosome 11, and rat chromosome 10.
    Islam MQ, Fång G, Islam K, Levan G.
    Mamm Genome; 1995 Dec 08; 6(12):882-4. PubMed ID: 8747929
    [No Abstract] [Full Text] [Related]

  • 34. Loss of heterozygosity or intragenic mutation, which comes first?
    Wilentz RE, Argani P, Hruban RH.
    Am J Pathol; 2001 May 08; 158(5):1561-3. PubMed ID: 11337351
    [No Abstract] [Full Text] [Related]

  • 35. p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells.
    Matozaki T, Sakamoto C, Suzuki T, Matsuda K, Uchida T, Nakano O, Wada K, Nishisaki H, Konda Y, Nagao M.
    Cancer Res; 1992 Aug 15; 52(16):4335-41. PubMed ID: 1322785
    [Abstract] [Full Text] [Related]

  • 36. [Chromosomes and cancer of the colon].
    De Juan Martín M.
    Rev Esp Enferm Apar Dig; 1989 Nov 15; 76(5):473. PubMed ID: 2616857
    [No Abstract] [Full Text] [Related]

  • 37. High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder.
    Gonzalez-Zulueta M, Shibata A, Ohneseit PF, Spruck CH, Busch C, Shamaa M, El-Baz M, Nichols PW, Gonzalgo ML, Elbaz M [corrected to El-Baz M].
    J Natl Cancer Inst; 1995 Sep 20; 87(18):1383-93. PubMed ID: 7658499
    [Abstract] [Full Text] [Related]

  • 38. [Code guideline for gastroenterology--a practical guide].
    Caspary WF, Frühmorgen P, Rosien U, Rösch T, Hummel F, Braun M, Loskamp N, Juhra C, Roeder N, Herausgegeben von der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten, DRG Research Group, Universitätsklinikum Münster.
    Z Gastroenterol; 2003 Feb 20; 41(2):207-30. PubMed ID: 12650131
    [No Abstract] [Full Text] [Related]

  • 39. Aberrant nuclear p53 expression predicts hemizygous 17p (TP53) deletion in chronic lymphocytic leukemia.
    Chang H, Jiang AM, Qi CX.
    Am J Clin Pathol; 2010 Jan 20; 133(1):70-4. PubMed ID: 20023260
    [Abstract] [Full Text] [Related]

  • 40. The p53 stabilizing compound CP-31398 induces apoptosis by activating the intrinsic Bax/mitochondrial/caspase-9 pathway.
    Luu Y, Bush J, Cheung KJ, Li G.
    Exp Cell Res; 2002 Jun 10; 276(2):214-22. PubMed ID: 12027451
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.